PropertyValue
?:abstract
  • The COVID-19 pandemic has resulted in a substantial increase in waiting times for cystoscopies, prompting concerns of delayed diagnoses and substandard surveillance of bladder cancer. Expanding the role of urinary biomarkers in diagnostic and surveillance pathways could be a strategy to address this problem, and several novel biomarkers have shown promise for this purpose.
is ?:annotates of
?:creator
?:doi
  • 10.1038/s41585-020-00419-z
?:doi
?:journal
  • Nat_Rev_Urol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/0b56d195b0d435ec8484c6a6cdbf6eeb08e2ba47.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7745709.xml.json
?:pmcid
?:pmid
?:pmid
  • 33335321.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era
?:type
?:year
  • 2020-12-17

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/a1voz79z>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/a1voz79z>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all